Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05020496
EARLY_PHASE1
Trem-1 and Ultraviolet Radiation-induced Immune Suppression
Sponsor: University of Alabama at Birmingham
View on ClinicalTrials.gov
Summary
The overall goal of this study is to determine novel mechanisms for ultraviolet light (UV)-induced suppression of the immune system in human subjects and to improve understanding of UV-induced skin carcinogenesis.
Official title: Role of Trem-1 in Ultraviolet Radiation-induced Immune Suppression
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2022-03-21
Completion Date
2026-10-01
Last Updated
2025-06-29
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Diphenylcyclopropenone (DPCP)
Drug will be applied topically on the skin. It will cause contact hypersensitivity in patients
Locations (1)
Whitaker Clinic
Birmingham, Alabama, United States